Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study.
Saleem F, Hassali MA, Shafie AA, Awad GA, Atif M, ul Haq N, Aljadhey H, Farooqui M.
BMC Public Health. 2012 Apr 30;12:318. doi: 10.1186/1471-2458-12-318.
Similar articles
Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
Elezaby RS, Gad HA, Metwally AA, Geneidi AS, Awad GA.
J Control Release. 2017 Sep 10;261:43-61. doi: 10.1016/j.jconrel.2017.06.019. Epub 2017 Jun 23. Review.
Polysaccharides-based nanocomplexes for the prolonged delivery of enoxaparin: In-vitro and in-vivo evaluation.
Ibrahim SS, Osman R, Awad GAS, Mortada ND, Geneidi AS.
Int J Pharm. 2017 Jun 30;526(1-2):271-279. doi: 10.1016/j.ijpharm.2017.05.007. Epub 2017 May 4.
<sup>131</sup>I-trazodone: preparation, quality control and in vivo biodistribution study by intranasal and intravenous routes as a hopeful brain imaging radiopharmaceutical.
Motaleb MA, Ibrahim IT, Sayyed ME, Awad GAS.
Rev Esp Med Nucl Imagen Mol. 2017 Nov - Dec;36(6):371-376. doi: 10.1016/j.remn.2017.03.001. Epub 2017 Apr 27. English, Spanish.
Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors.
Ramzy L, Nasr M, Metwally AA, Awad GAS.
Eur J Pharm Sci. 2017 Jun 15;104:273-292. doi: 10.1016/j.ejps.2017.04.005. Epub 2017 Apr 12. Review.
Passive targeting and lung tolerability of enoxaparin microspheres for a sustained antithrombotic activity in rats.
Ibrahim SS, Osman R, Mortada ND, Geneidy AS, Awad GA.
Drug Deliv. 2017 Nov;24(1):243-251. doi: 10.1080/10717544.2016.1245368.
Synthesis and evaluation of alendronate-modified gelatin biopolymer as a novel osteotropic nanocarrier for gene therapy.
Mekhail GM, Kamel AO, Awad GA, Mortada ND, Rodrigo RL, Spagnuolo PA, Wettig SD.
Nanomedicine (Lond). 2016 Sep;11(17):2251-73. doi: 10.2217/nnm-2016-0151. Epub 2016 Aug 16.
Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies.
El-Zaafarany GM, Soliman ME, Mansour S, Awad GA.
Int J Pharm. 2016 Apr 30;503(1-2):127-40. doi: 10.1016/j.ijpharm.2016.02.038. Epub 2016 Mar 14.
Dextran-based Nanocarriers for Delivery of Bioactives.
Ishak RA, Osman R, Awad GA.
Curr Pharm Des. 2016;22(22):3411-28. Review.
Tunable Biodegradable Nanocomposite Hydrogel for Improved Cisplatin Efficacy on HCT-116 Colorectal Cancer Cells and Decreased Toxicity in Rats.
Abdel-Bar HM, Osman R, Abdel-Reheem AY, Mortada N, Awad GA.
Biomacromolecules. 2016 Feb 8;17(2):407-14. doi: 10.1021/acs.biomac.5b01206. Epub 2016 Jan 14.
Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery.
Ibrahim SS, Osman R, Awad GA, Mortada ND, Geneidy AS.
Drug Deliv. 2016 Oct;23(8):2661-2667. Epub 2015 Jun 9. Review.
Defining cisplatin incorporation properties in thermosensitive injectable biodegradable hydrogel for sustained delivery and enhanced cytotoxicity.
Abdel-Bar HM, Abdel-Reheem AY, Osman R, Awad GA, Mortada N.
Int J Pharm. 2014 Dec 30;477(1-2):623-30. doi: 10.1016/j.ijpharm.2014.11.005. Epub 2014 Nov 6.
Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats.
Elmowafy E, Osman R, El-Shamy AH, Awad GA.
Int J Nanomedicine. 2014 Sep 18;9:4449-65. doi: 10.2147/IJN.S66876. eCollection 2014.
Impact of microparticle formulation approaches on drug burst release: a level A IVIVC.
Ishak RA, Mortada ND, Zaki NM, El-Shamy Ael-H, Awad GA.
J Microencapsul. 2014;31(7):674-84. doi: 10.3109/02652048.2014.913724. Epub 2014 Jun 25.
Nasal polysaccharides-glucose regulator microparticles: optimization, tolerability and antidiabetic activity in rats.
Elmowafy E, Osman R, El-Shamy Ael-H, Awad GA.
Carbohydr Polym. 2014 Aug 8;108:257-65. doi: 10.1016/j.carbpol.2014.02.064. Epub 2014 Feb 28.
Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo.
El-Gogary RI, Rubio N, Wang JT, Al-Jamal WT, Bourgognon M, Kafa H, Naeem M, Klippstein R, Abbate V, Leroux F, Bals S, Van Tendeloo G, Kamel AO, Awad GA, Mortada ND, Al-Jamal KT.
ACS Nano. 2014 Feb 25;8(2):1384-401. doi: 10.1021/nn405155b. Epub 2014 Jan 23.
Chlorpromazine versus placebo for schizophrenia.
Adams CE, Awad GA, Rathbone J, Thornley B, Soares-Weiser K.
Cochrane Database Syst Rev. 2014 Jan 6;(1):CD000284. doi: 10.1002/14651858.CD000284.pub3. Review.
Similar articles 1 comment
Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging.
Sakr TM, El-Safoury DM, Awad GA, Motaleb MA.
J Labelled Comp Radiopharm. 2013 Jun 30;56(8):392-5. doi: 10.1002/jlcr.3060. Epub 2013 May 22.
Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam.
Abdel-Bar HM, Abdel-Reheem AY, Awad GA, Mortada ND.
J Pharm Pharm Sci. 2013;16(3):456-69.
A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution.
Ishak RA, Awad GA, Zaki NM, El-Shamy Ael-H, Mortada ND.
Carbohydr Polym. 2013 Apr 15;94(1):669-76. doi: 10.1016/j.carbpol.2013.01.072. Epub 2013 Feb 8.
Filters: Manage Filters